Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29773669.
- Also identified by DOI 10.1126/science.aao4908 and PMC identifier 6547380.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The majority of patients with pancreatic ductal adenocarcinoma (PDA) develop metastatic disease after resection of their primary tumor. We found that livers from patients and mice with PDA harbor single disseminated cancer cells (DCCs) lacking expression of cytokeratin 19 (CK19) and major histocompatibility complex class I (MHCI). We created a mouse model to determine how these DCCs develop. Intraportal injection of immunogenic PDA cells into preimmunized mice seeded livers only with single, nonreplicating DCCs that were CK19<sup>-</sup> and MHCI<sup>-</sup> The DCCs exhibited an endoplasmic reticulum (ER) stress response but paradoxically lacked both inositol-requiring enzyme 1α activation and expression of the spliced form of transcription factor XBP1 (XBP1s). Inducible expression of XBP1s in DCCs, in combination with T cell depletion, stimulated the outgrowth of macrometastatic lesions that expressed CK19 and MHCI. Thus, unresolved ER stress enables DCCs to escape immunity and establish latent metastases.
Medical subject headings
- Carcinoma, Pancreatic Ductal
- Endoplasmic Reticulum Stress
- Liver Neoplasms
- Pancreatic Neoplasms
- Tumor Escape